Not provided
Not provided
Not provided
Not provided
Change of practice to antibiotic impregnated catheters and large study published showing their efficacy. Made topical antibiotics obselete.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to determine if the overall central venous catheter related infection rate can be reduced by the application of Polysporin Triple Therapy ointment to the insertion site.
Previous studies in the dialysis population have found a reduction in local and system central venous catheter related infections with the application of topical antibiotics to the insertion point. One such study found a mortality benefit with Polysporin Triple Therapy ointment. We intend to determine if this preparation can reduce overall line infection rates in the ICU environment through its application at the time of line insertion and twice more the following week.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Polysporin Triple Therapy | Experimental | Polysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week. |
|
| Placebo | Placebo Comparator | Petroleum jelly |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Polysporin Triple Therapy ointment | Drug | Polysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Overall number of line related infections (local and blood borne) | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Length of ICU stay | 7 months | |
| Length of hospital stay | 7 months | |
| Prevalence of methicillin-resistant Staphylococcus Aureus (MRSA) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Steven Reynolds, MD | Fraser Health Authority | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Royal Columbian Hospital | New Westminster | British Columbia | V3L 1A1 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 12506149 | Background | Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003 Jan;14(1):169-79. doi: 10.1097/01.asn.0000038688.76195.a4. | |
| 18413621 | Background | James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med. 2008 Apr 15;148(8):596-605. doi: 10.7326/0003-4819-148-8-200804150-00004. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012874 | Skin Diseases, Infectious |
| D055499 | Catheter-Related Infections |
| ID | Term |
|---|---|
| D007239 | Infections |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006096 | Gramicidin |
| D001414 | Bacitracin |
| D010577 | Petrolatum |
| ID | Term |
|---|---|
| D014449 | Tyrothricin |
| D010456 | Peptides, Cyclic |
| D047028 | Macrocyclic Compounds |
| D011083 | Polycyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Petroleum Jelly | Other | Petroleum jelly applied to the insertion point at the time of CVC placement and twice within the first week. |
|
|
| 12 months |
| D010455 |
| Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D052899 | Pore Forming Cytotoxic Proteins |
| D008565 | Membrane Proteins |
| D011506 | Proteins |
| D006838 | Hydrocarbons |
| D009930 | Organic Chemicals |